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Background: Hepatitis A virus (HAV) epidemiology in Tunisia has changed from high to intermediate endemicity
in the last decades. However, several outbreaks continue to occur. The last reported sequences from Tunisian HAV
strains date back to 2006. In order to provide an updated overview of the strains currently circulating in Tunisia,
a large-scale molecular analysis of samples from hepatitis A cases was performed, the first in Tunisia.
Results: Biological samples were collected from patients with laboratory confirmed hepatitis A: 145 sera samples in
Tunis, Monastir, Sousse and Kairouan from 2008 to 2013 and 45 stool samples in Mahdia in 2009. HAV isolates were
characterised by nested RT-PCR (VP1/2A region) and sequencing. The sequences finally obtained from 81 samples
showed 78 genotype IA and 3 genotype IB isolates.
A Tunisian genotype IA sequence dataset, including both the 78 newly obtained IA sequences and 51 sequences
retrieved from GenBank, was used for phylogenetic investigation, including analysis of migration pattern among
six towns. Virus gene flow from Sfax and Monastir was directed to all other towns; in contrast, the gene flows from
Sousse, Tunis, Mahdia and Kairouan were directed to three, two, one and no towns, respectively.
Conclusions: Several different HAV strains co-circulate in Tunisia, but the predominant genotype still continues to
be IA (78/81, 96% isolates). A complex gene flow (migration) of HAV genotype IA was observed, with Sfax and
Monastir showing gene flows to all other investigated towns. This approach coupled to a wider sampling can prove
useful to investigate the factors underlying the spread of HAV in Tunisia and, thus, to implement appropriate
preventing measures.
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Hepatitis A virus (HAV), a member of the family Picor-
naviridae, genus Hepatovirus, is the major cause of
acute hepatitis throughout the world and causes sub-
stantial morbidity in both developed and developing
countries [1].
HAV is mainly transmitted by the faecal-oral route.
HAV can survive for long in water and numerous epi-
demics have been observed following consumption of
contaminated drinking water, food produce and shellfish
[2-10]. The true incidence of hepatitis A is often* Correspondence: roberto.bruni@iss.it
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unless otherwise stated.underestimated because of under-reporting as a result of
its widely asymptomatic and milder forms of infection;
thus, the epidemiologic pattern is indicated primarily by
its seroprevalence.
The epidemiology of HAV is highly correlated with
level of hygiene and age. In developing countries, poor
sanitary and hygienic conditions, low economic status,
high crowding and inadequate water treatment contrib-
ute to a high endemicity pattern; the majority of children
acquires infection (most often asymptomatic) during
early childhood [11,12]. Thus, in these countries overt
forms of hepatitis A are relatively rare and severe forms
are exceptional [13,14]. The epidemiologic pattern of
hepatitis A infection is currently changing in many
developing countries where socio-economic conditionstral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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later age, leading to an increased risk of symptomatic
and more severe forms of disease that typically occur in
adulthood [15-18]. Recently, two reviews analysed pub-
lished data on anti-HAV seroprevalence in countries of
North and West Africa and Middle East and reported a
gradual shift in the age of infection from early childhood
to late childhood or adulthood, indicating a shift towards
intermediate endemicity in these areas [19,20].
In Tunisia, HAV epidemiology has changed from a
high to an intermediate endemicity pattern, particularly
in urban areas [11]. Improvement of hygiene and socio-
economic conditions has undoubtedly contributed to
this epidemiologic shift. However, seroprevalence rates
are still more elevated than those reported in European
countries. Child infection rates remain high, with differ-
ences between urban and rural settings, depending on
the development of the considered areas [11,12,21].
Lower anti-HAV prevalences were found in coastal re-
gions, as compared to the rest of the country: this differ-
ence may be due to the higher socioeconomic level of
the coastal populations [22]. Although HAV incidence
has declined over the past decades, in Tunisia many out-
breaks continue to occur.
Based on nucleotide sequence analysis, human HAV is
classified in 3 genotypes (I, II and III) and sub-classified
in 6 sub-genotypes (IA, IB, IIA, IIB, IIIA, IIIB). Molecu-
lar characterization of HAV strains from Tunisian pa-
tients showed a clear predominance of sub-genotype IA
(about 98%), compared to sub-genotype IB (2%); no II
and III genotypes were found [23,24].
In the present study, samples collected in different
towns in Tunisia during 2008–2013 from patients with
acute hepatitis A were analysed by nested RT-PCR and
sequencing to characterize HAV isolates. Tunisian HAV
sequences, both from the present study and downloaded
from Genbank and overall including cases from 2001 to
2013, were analysed by phylogenetic and migration pat-
tern analyses to investigate, for the first time, the viral
gene flow of HAV in Tunisian towns.
Results
Virological characterization of HAV isolates
HAV RNA tested positive by nested RT-PCR in 81 of
190 analysed samples collected in different Tunisian
towns during 2008–2013. The features of the PCR posi-
tive group were not dissimilar from those of the total
group of patients included in the study (described in the
Methods section): the mean age of the 81 patients was
9.7 years, the median age was 8.0 years and the age
range was 2–60 years; 45 patients were males (55.6%)
and 36 females (44.4%). Sequencing of the 81 PCR prod-
ucts followed by phylogenetic analysis with genotype refer-
ence sequences showed that most isolates (78/81, 96.3%)were genotype IA, while only three sequences, all from
Tunis patients, were genotype IB (3/81, 3.7%) (Figure 1).
Pair-wise comparisons of the sequenced VP1/2A re-
gion of isolated genotype IA strains revealed a genetic
identity level ranging from 94.8% to 100%. The same
identity range was obtained by including in the analysis
Tunisian strains downloaded from Genbank.
Figure 2 shows the phylogenetic tree of 129 genotype
IA isolates from six Tunisian towns. The presence of
several distinct clusters in the phylogenetic tree revealed
the circulation of different genotype IA strains.
Migration pattern of HAV Tunisian IA genotype
The gene flow (migration) of HAV genotype IA among 6
major towns in Tunisia (A: Sfax, B: Sousse, C: Mahdia,
D: Monastir, E: Tunis and F: Kairouan) was investigated
with a modified version of the Slatkin and Maddison
method [25]. After superimposing the town of origin of
the Tunisian sequences on the tip branches of the ML
genealogy, we inferred the town of origin of each ances-
tral node (i.e. ancestral sequence) using the maximum
parsimony algorithm. The null hypothesis of panmixia
(i.e. no population subdivision or complete intermixing
of sequences from different geographical areas) was
tested using a bubblegram. The migration flow among
the six towns was then estimated as observed migration in
the genealogy (Figure 3). The null hypothesis of panmixia
was rejected by the randomization test (p = 0.0001) for all
the towns in the bubblegram [26].
As shown by the bubblegram in Figure 3, the viral
gene flow from each of two towns (Sfax and Monastir)
appears to be directed to all the others: the flow from
Sfax is directed mainly to Sousse (50%) and to a less ex-
tent to Monastir (25%), Mahdia (8.3%), Tunis (8.3%) and
Kairouan (8.3%); the flow from Monastir appears more
equally distributed among the five towns (Sfax 12.5%,
Sousse 12.5%, Mahdia 25%, Tunis 37.5% and Kairouan
12.5%) (Figure 3). On the other hand, the viral gene flow
from Sousse was equally distributed towards three of the
five towns (Sfax, Monastir and Tunis, 33.3% each), while
Tunis showed viral gene flow towards only two towns
(mainly to Mahdia, 75%; to a less extent to Monastir,
25%); finally, the flow from Mahdia was directed exclu-
sively to one town (Monastir, 100%). No viral gene
flow from Kairouan to the other towns was observed.
Overall, a complex viral gene flow among the considered
Tunisian towns emerges, as schematically summarised in
Figure 4.
Discussion
Although the incidence of infection in Tunisia has de-
clined over the last years, HAV outbreaks continue to
occur [11,24]. Person-to-person transmission and con-
sumption of contaminated water are main risk factors
Figure 1 Maximum likelihood phylogenetic analysis of HAV sequences (VP1/2A region). Phylogenetic tree of 81 HAV sequences from
Sousse, Mahdia, Monastir, Tunis and Kairouan and 27 reference sequences (genotype I, II, III and V) downloaded from GenBank. The 81 sequences
from Tunisia are highlighted in red; their name includes, after a progressive number (1 to 81) followed by “Tu”, a capital letter indicating the town
from which the sample was collected (A: Sfax; B: Sousse; C: Mahdia; D: Monastir; E: Tunis; F: Kairouan) and, at the end of the name, the sampling
year (e.g. _09 stands for 2009, _10 stands for 2010, and so on). See Methods for further details. The 27 reference sequences are reported by their
Accession number followed by the genotype they belong to. Branch lenghts were estimated with the best fitting nucleotide substitution model
(TrN + I + G) according to a hierarchical likelihood ratio test [38], the scale bar at the bottom indicates 0.04 nucleotide substitutions per site. One
*along a branch represents significant statistical support for the clade subtending that branch (p < 0.001 in the zero-branch-lenght test and
bootstrap support >75%).
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sumption, especially raw shellfish due to their bio-
concentrator ability, could also play a potential role in
transmission, because of residual HAV contamination of
effluents from waste water treatment plants [2,28,29].
Moreover, climatic conditions, soil leaching caused by
heavy winter rainfalls, and the use of unsanitised sludge
as crop fertiliser are further factors that may explain the
intensity of the epidemics during the winter [30].
Most Tunisian sequences reported in previous studies
(spanning the 329 nt region sequenced in the present
study) were collected from two towns (Sfax and Sousse)
and the most recent of them date back to 2006 [23,24].In those studies, the authors showed circulation of dif-
ferent HAV IA strains, some of them genetically related
to strains isolated in other Mediterranean countries.
The present study is the first large-scale molecular study
analysing clinical sequences from six Tunisian towns, some
of them never sampled in the past; in addition, it represents
an updated overview of the strains circulating in Tunisia.
The great majority of isolates (78/81, 96.7%) proved to be
genotype IA, in agreement with previous studies that
reported about 98% HAV IA strains both in clinical and in
environmental samples in Tunisia [23,24,29-31].
The circulation of different genotype IA strains is sup-
ported by the presence of several distinct clusters in the
Figure 2 Maximum likelihood phylogenetic analysis of HAV genotype IA sequences (VP1/2A region). Phylogenetic tree of 129 genotype
IA Tunisian HAV sequences from six Tunisian towns (78 new sequences from the present study and 51 reference sequences from GenBank).
Branch lenghts were estimated with the best fitting nucleotide substitution model (HKY + G) according to a hierarchical likelihood ratio test [38],
the scale bar at the bottom indicates 0.02 nucleotide substitutions per site. One *along a branch represents significant statistical support for the
clade subtending that branch (p < 0.001 in the zero-branch-lenght test and bootstrap support >75%). The 78 sequences from the present study
are highlighted in red, the 51 reference sequences in blue. Sequence names of new and reference sequences include town and year of sample
collection (see the “Sequence datasets” section in Methods).
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studies (Figure 2). This pattern is in accordance with the
sampling mode (samples were collected randomly during
multiple years, not in an outbreak) and confirms that
different strains co-circulate in Tunisia [23].
Ten clinical strains characterized in the present study
proved to be identical to the majority of IA strains found
in urban wastewaters in Tunisia [29]; in particular, a
strain detected in a patient from Tunis in 2012 was
identical to the most prevalent environmental strain,
found in 42 wastewater samples [29]. Importantly, the
above ten strains were characterized from samples recentlycollected (2008 to 2013) from patients in Tunisian regions
not previously investigated: this finding confirms current
extensive circulation of clinical strains in the environment,
suggesting the importance of implementing a clinical-
environmental surveillance system, to monitor the efficacy
of preventive and control measures.
In the present study either serum or stool was sam-
pled, which can raise concerns for possible introduction
of a bias in the gene migration pattern analysis due to
slight sequence differences between virions in serum and
in stool. Actually, this possibility is unlikely because a
recent study showed that identical HAV sequences are
Figure 3 Migration pattern of HAV genotype IA circulation in Tunisia. The bubblegram shows the frequency of gene flow (migrations) in
Tunisia to/from different geographic areas (towns). The surface of each circle is proportional to the percentage of observed migrations in the ML
genealogy. Migrations were inferred with a modified version of the Slatkin and Maddison algorithm [25,26] for the HAV subtype IA from the
maximum likelihood inferred genealogies given in Figure 2. A: Sfax; B: Sousse; C: Mahdia; D: Monastir; E: Tunis; F: Kairouan.
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saliva and urine) of the same patient [32].
Migration analysis showed a complex virus gene flow
among the towns considered in the present study. How-
ever, examination of Figure 3 suggests (1) an overall
South-to-North major flow from Sfax to Sousse and, to a
less extent, to Monastir, and from these two latter towns to
Tunis, and (2) an overall North-to-South major flow from
Tunis to Mahdia and then (3) from Mahdia again South-
to-North to Monastir; a complex pattern of minor flows is
also visible. Multiple factors are likely involved in deter-
mining the observed flows: demographic (population size
and movement), climatic (the floods frequently occurring
in the raining season), economic (food trade); the under-
lying infrastructures may also play a role (such as the lack
of an extensive and widespread distribution of sewage sys-
tems). Interactions between these factors, as in the case of
floods and poor sewage systems, may determine the opti-
mal conditions for spread of an enterically transmitted and
highly environmental resistant agent such as HAV.
Conclusions
In conclusion, this is the first study describing by a
migration pattern approach the circulation of HAV in
North-Central Tunisia towns. Currently, genotype IApredominates widely, with several newly and previously
identified strains. The viral gene flow analysis of the
present study, coupled to a wider sampling, can be use-
ful to investigate the factors underlying the spread of




Serum or stool samples were collected from 190 patients
with symptoms of acute hepatitis as part of standard
care: serum samples from 145 patients hospitalized in
Tunis (44 patients, Hospital Charles Nicolle; Hospital
Rabta; Pasteur Institute), Sousse (26 patients, Hospital
Farhat Hached), Monastir (61 patients, Hospital Fattouma
Bourguiba), Kairouan (14 patients, Hospital Ibnou El
Jazzar) in 2008–2013; stool samples from 45 hospitalized
patients by the Regional Direction of Public Health in
Mahdia in a one year survey during 2009. The study was in
compliance with the Helsinki Declaration and was ap-
proved by the Ethic Committee of Hôpital Universitaire
Fattouma, Monastir (President of the Ethic Committee:
Prof. Fekri Abroug).
The mean age of the 190 patients was 12.4 years, the
median age was 9 years and the age range was 2–66
Figure 4 Detailed mapping of HAV IA gene flow (coloured
arrows) among some North-Central Tunisian towns. The line
thickness of the arrows is roughly proportional to the percentage of
observed migrations.
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(43%). Informed consent for characterization of virus in
samples was obtained before patient discharge. The
study conformed to the Declaration of Helsinki. All
cases were diagnosed locally as HAV infections on the
basis of serum antibody detection by a commercial test
(Abbott Architect HAVAB-M, Abbott Diagnostics, Ab-
bott Park, Illinois). Virological analysis of samples was
carried out by HAV RNA detection and sequencing at
the Viral Hepatitis Unit of the Italian National Institute
of Health in Rome.
Nested RT-PCR and Sequencing
Viral RNA extraction from all samples (sera and stools)
was carried out by the QIAamp Viral RNA Mini Kit
(Qiagen GmbH, Hilden, Germany). For serum, a 140 μl
volume was extracted according to the manufacturer’s
protocol. For stools, a modified protocol downloadedfrom the QIAGEN site, including an additional prelimin-
ary step, was used [33]. In the additional preliminary
step, 0.2 ml of stool was carefully suspended in 2 ml of
0.89% NaCl. The suspension was clarified by centrifuga-
tion for 20 min at 4,000 × g. The supernatant was fil-
tered using a 0.22 μm syringe filter (Millipore), and
140 μL of eluate was then used for HAV RNA extrac-
tion. The remainder of the procedure is common to
stool and serum. The RNA was recovered in 60 μL elu-
tion buffer and a 394 base pairs (bp) DNA fragment
spanning the VP1/2A junction of HAV genome was
amplified by nested RT-PCR as previously reported, with
minor modifications [34]. In order to increase the sensi-
tivity, a nested PCR approach was preferred. In brief,
10 μL extracted RNA was reverse transcribed with
2.5 μM random hexamers (final concentration) and 200
U of Moloney Murine Leukemia Virus reverse tran-
scriptase (Invitrogen, by Life Technologies, Carlsbad,
CA) in a final volume of 20 μL at 50°C for 1 hr, followed
by 15 min at 70°C. One-half cDNA volume (10 μL) was
used as template in the first PCR round. After denatur-
ation for 2 min at 94°C, DNA was amplified in a 50 μL
final volume for 30 cycles at 94°C for 30 sec, 40°C for
30 sec, and 72°C for 1 min, followed by a final extension
step at 72°C for 7 min. Reaction mixture was as follows:
1X PCR buffer, 1.5 mM MgCl2, 0.2 mM each dNTP,
1 μM each primer, with 1 U of Platinum Taq DNA
polymerase per 50 μL reaction (Invitrogen, by Life
Technologies, Carlsbad, CA).
In order to improve the ability to amplify any HAV geno-
type, a modified degenerated version of previously pub-
lished primers was used [33]. Primers in the first round of
PCR were: sense +2870 (5′-GACAGATTCYACATTTG
GATTGGT-3′) and antisense −3381 (5′-CCATYTCAA
GAGTCCACACACT-3′), where Y represents C or T.
Nested PCR was carried out with 0.5 ul of the first round
PCR product as template for 35 cycles, with the same reac-
tion and cycling conditions of the first PCR. Inner primers
were: sense +2896 (5′-CTATTCAGATTGCAAATTAYA
AT-3′) and antisense −3289 (5′-AAYTTCATYATTT
CATGCTCCT-3′). PCR products (10 ul) were loaded on a
2% agarose gel, electrophoresed and stained with ethidium
bromide to visualize bands of expected size (394 bp).
PCR products were sequenced using the GenomeLab
DTCS Quick Start KiT (Beckman Coulter, Fullerton,
CA) following the manufacturer’s instructions, with the
same primers used in nested PCR (sense +2896 and anti-
sense −3289, see above) and an automated DNA sequencer
(Beckman Coulter, Fullerton, CA). After editing and align-
ment, a common 329 nt region was available for analysis.
Sequence datasets
The 81 Tunisian HAV sequences from the present study
have been deposited in GenBank [GenBank:KP091352 to
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and 2, were coded as follows: a progressive number (1 to
81), followed by “Tu” and a capital letter (A, B, C, D, E
or F) indicating the sampling town (A: Sfax; B: Sousse;
C: Mahdia; D: Monastir; E: Tunis; F: Kairouan) and,
finally, the sampling year preceded by “_”. For instance,
27TuD_13 indicates the Tunisian sequence 27, sampled
in Monastir in 2013.
Two sequence datasets were built. The first one was
built to determine the genotype of each isolate and in-
cluded all the 81 newly obtained sequences plus 27 ref-
erence sequences from several countries representative
of genotypes I, II, III (human strains) and V (a simian
strain), downloaded from the GenBank database via the
National Center for Biotechnology Information (NCBI) site
[35]. The list of the Accession Number of the 27 reference
sequences retrieved from GenBank follows. Genotype IA:
AF357222; AB020565; AB020564; AB020567; AB020566;
AB020568); AB020569; AF485328; AF512536; X75215;
X83302; AY974170; K02990. Genotype IB: M14707;
M20273; AF268396; AF314208. Genotype IIA: AY644676.
Genotype IIB: AY644670. Genotype IIIA: AJ299464;
AY644337; AB279732; AB279733; AB279734. Genotype
IIIB: AB258387; AB279735. Genotype V (simian virus):
D00924.
The second dataset was built to perform phylogenetic
analysis and viral gene flow exclusively on genotype IA
Tunisian sequences. This dataset included 78 new se-
quences from the present study (identified as genotype
IA among the above 81 new sequences) and 51 Tunisian
sequences downloaded from GenBank. These latter se-
quences were selected according to the following inclusion
criteria, based on information available from sequence an-
notations or from published studies: (1) known sampling
town; (2) known sampling year. Their names were
coded exactly as the newly obtained sequences (see
above): a number (82 to 132, to continue the progressive
numbering) followed by “Tu”, then a capital letter (A, B, C,
D, E or F) indicating the sampling town and, finally, the
sampling year preceded by “_”. The list of the 51 down-
loaded Tunisian sequences collected in Sfax, Sousse,
Mahdia and Monastir from 2001 to 2006 with matched
Accession Number (in parentheses) follows: 82TuB_03
(AY875650); 83TuB_03 (AY875651); 84TuB_02
(AY875652); 85TuB_03 (AY875653); 86TuA_03
(AY875654); 87TuC_03 (AY875655); 88TuB_02
(AY875656); 89TuB_01 (AY875657); 90TuB_03
(AY875659); 91TuB_03 (AY875660); 92TuB_02
(AY875661); 93TuB_03 (AY875662); 94TuD_01
(AY875663); 95TuB_01 (AY875664); 96TuA_03
(AY875665); 97TuA_03 (AY875666); 98TuA_03
(AY875667); 99TuA_04 (AY875668); 100TuA_04
(AY875669); 101TuA_04 (AY875670); 102TuB_04
(AY875671); 103TuB_01 (AY875672); 104TuA_03(DQ380510); 105TuA_03 (DQ380511); 106TuA_03
(DQ380512); 107TuA_03 (DQ380513); 108TuA_03
(DQ380514); 109TuA_03 (DQ380515); 110TuA_03
(DQ380516); 111TuA_03 (DQ380517); 112TuA_03
(DQ380518); 113TuA_03 (DQ380519); 114TuA_03
(DQ380520); 115TuA_03 (DQ380521); 116TuA_03
(DQ380522); 117TuA_03 (DQ380523); 118TuA_03
(DQ380524); 119TuA_06 (HM011106); 120TuA_06
(HM011107); 121TuA_06 (HM011108); 122TuA_06
(HM011109); 123TuA_06 (HM011110); 124TuA_06
(HM011111); 125TuA_06 (HM011112); 126TuA_06
(HM011113); 127TuA_06 (HM011114); 128TuA_06
(HM011115); 129TuA_06 (HM011116); 130TuA_06
(HM011117); 131TuA_06 (HM011118); 132TuA_06
(HM011119).
Sequences were aligned with the Clustal algorithm
[36], then edited manually. The Tunisian genotype IA
dataset was subjected to a preliminary likelihood map-
ping analysis to assess if a suitable phylogenetic signal
could be detected, as previously described [37,38].
Phylogenetic analysis
The best fitting nucleotide substitution model was tested
with a hierarchical likelihood ratio test following the
strategy described by Swofford and Sullivan [38], using a
neighbour-joining (NJ) based-tree with LogDet corrected
distances. Maximum likelihood (ML) trees were then in-
ferred with the selected model and ML-estimated substi-
tution parameters. The heuristic search for the ML tree
was performed using a NJ tree as starting tree and the
TBR branch-swapping algorithm. NJ trees were also esti-
mated using pair-wise distances inferred by ML with the
best fitting nucleotide substitution model. Calculations
were performed with PAUP 4.0b10 [39]. Statistical sup-
port for internal branches in the NJ trees was obtained
by bootstrapping (1000 replicates) and with the ML-
based zero branch length test for the ML trees [38].
Trees were rooted by ML rooting by selecting the rooted
tree with the best likelihood under the molecular clock
constraint (taking into account the different sampling
times of the taxa) [40,41].
Migration pattern
The MacClade version 4 program (Sinauer Associates,
Sunderland, MA) was used to test viral gene in/out flow
among distinct HAV subpopulations within different
geographic regions and towns in Tunisia (from North
to South: Tunis, Sousse, Monastir, Kairouan, Mahdia
and Sfax), using a modified version of the Slatkin and
Maddison test as described below [25].
A one-character data matrix is obtained from the ori-
ginal data set by assigning to each taxon in the tree a
one-letter code indicating its city of origin. Then, the
putative origin of each ancestral sequence (i.e. internal
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monious reconstruction (MPR) of the ancestral charac-
ter. The final tree-length, i.e. the number of observed
migrations in the genealogy, can easily be computed and
compared to the tree-length distribution of 10,000 trees
obtained by random joining-splitting.
Observed genealogies significantly shorter than ran-
dom trees indicate the presence of subdivided popula-
tions with restricted gene flow [25]. Specific migrations
among different towns (character states) were traced
with the State changes and stasis tool (MacClade soft-
ware), which counts the number of changes in a tree for
each pair-wise character state. When multiple MPRs
were present (as in our data set), the algorithm calcu-
lated the average migration count over all possible MPRs
for each pair. The resulting pair-wise migration matrix
was then normalized, and a randomization test with
10,000 matrices obtained from 10,000 random trees
(by random joining-splitting of the original tree) was
performed to assess the statistical significance of the
observed migration counts.
Consent
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